Trump ’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.

Source: NYT Health - October 9, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli and Nathalia Holt Tags: your-feed-science United States Politics and Government Fetal Tissue Coronavirus (2019-nCoV) Abortion Vaccination and Immunization Antibodies Ethics and Official Misconduct Drugs (Pharmaceuticals) AstraZeneca PLC Eli Lilly and Company Source Type: news